Alpha- and beta-adrenergic agonists and antagonists

[1]  J. Lindholm,et al.  Controlled clinical study on antihypertensive treatment with a diuretic and methyldopa compared with a beta-blocking agent and hydralazine. , 2009, Acta medica Scandinavica.

[2]  L. Hansson,et al.  Treatment of hypertension with propranolol and hydralazine. , 2009 .

[3]  C. Regårdh,et al.  Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol. , 2009, Acta pharmacologica et toxicologica.

[4]  A. Hollister,et al.  Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. , 1983, The American journal of medicine.

[5]  J. Kjekshus,et al.  Timolol‐related Reduction in Mortality and Reinfarction in Patients Ages 65‐75 Years Surviving Acute Myocardial Infarction , 1982, Circulation.

[6]  R. Woosley,et al.  Effects of Concentration and Steric Configuration of Propranolol on AV Conduction and Ventricular Repolarization in the Dog , 1981, Journal of Cardiovascular Pharmacology.

[7]  J. Wilson,et al.  HAS THE CHANGE TO BETA-AGONISTS COMBINED WITH ORAL THEOPHYLLINE INCREASED CASES OF FATAL ASTHMA? , 1981, The Lancet.

[8]  S. Olsson,et al.  Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man. , 1981, British heart journal.

[9]  D. Robertson,et al.  Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. , 1981, The Journal of clinical investigation.

[10]  J. Oates,et al.  α-Methylepinephrine, a methyldopa metabolite that binds to α-receptors in rat brain , 1981 .

[11]  P. Puddu,et al.  Effect of intravenous propranolol on QT interval. , 1980, British heart journal.

[12]  T. Walle,et al.  Propranolol effects on membrane repolarization time in isolated canine Purkinje fibers: threshold tissue content and the influence of exposure time. , 1980, The Journal of pharmacology and experimental therapeutics.

[13]  J. Doherty,et al.  The long-term suppression of ventricular arrhythmia by oral acebutolol in patients with coronary artery disease. , 1980, American heart journal.

[14]  S. Olsson,et al.  Sotalol-induced delayed ventricular repolarization in man. , 1980, European heart journal.

[15]  L. Horwitz,et al.  Adrenergic Responsiveness After Abrupt Propranolol Withdrawal in Normal Subjects and in Patients with Angina Pectoris , 1980, Circulation.

[16]  C. H. Beckmann,et al.  Propranolol therapy for ventricular arrhythmias 2 months after acute myocardial infarction. , 1980, The American journal of cardiology.

[17]  P. Jaillon,et al.  A model to describe myocardial drug disposition in the dog. , 1980, The Journal of pharmacology and experimental therapeutics.

[18]  T. Blaschke,et al.  Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose. , 1980, British journal of clinical pharmacology.

[19]  Perry,et al.  Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. , 1980, The Journal of clinical investigation.

[20]  J. Hampton,et al.  Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. , 1980, British medical journal.

[21]  Silverman Wa.  Non-treatment of defective newborn babies. , 1980, Lancet.

[22]  A. Camm,et al.  Effect of intravenous propranolol on QT interval. A new method of assessment. , 1980, British heart journal.

[23]  E. Eisenberg,et al.  Seizures and intraventricular conduction defect in propranolol poisoning. A report of two cases. , 1979, Annals of internal medicine.

[24]  J. Oates,et al.  Suppression of Chronic Ventricular Arrhythmias with Propranolol , 1979, Circulation.

[25]  L. Benet,et al.  Attenuation of prazosin effect on cardiac output in chronic heart failure. , 1979, Annals of internal medicine.

[26]  R. Vestal,et al.  Reduced β‐adrenoceptor sensitivity in the elderly , 1979 .

[27]  R. Branch,et al.  Effects of age and cigarette smoking on propranolol disposition , 1979, Clinical pharmacology and therapeutics.

[28]  R. Branch,et al.  Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination , 1979, Clinical pharmacology and therapeutics.

[29]  R. Rangno,et al.  Mechanism of Propranolol Withdrawal Phenomena , 1979, Circulation.

[30]  D. Robertson,et al.  Contraindication to the use of ocular phenylephrine in idiopathic orthostatic hypotension. , 1979, American journal of ophthalmology.

[31]  J. Oates,et al.  Comparative Assessment of Stimuli That Release Neuronal and Adrenomedullary Catecholamines in Man , 1979, Circulation.

[32]  L. Gould,et al.  Oral therapy with phentolamine in chronic congestive heart failure. , 1979, Chest.

[33]  W. Addington,et al.  Arrhythmogenic effects of orally administered bronchodilators. , 1979, Archives of internal medicine.

[34]  R. Vukovich,et al.  Elimination of nadolol by patients with renal impairment. , 1979, British journal of clinical pharmacology.

[35]  U. Smith,et al.  EFFECT OF CARDIOSELECTIVE AND NON-SELECTIVE β-BLOCKADE ON THE HYPOGLYCÆMIC RESPONSE IN INSULIN-DEPENDENT DIABETICS , 1979, The Lancet.

[36]  R. Gorlin,et al.  Hemodynamic and Clinical Tachyphylaxisc to Prazosin-Mediated Afterload Reductionin Severe Chronic Congestive Heart Failure , 1979, Circulation.

[37]  W. Aronow,et al.  Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.

[38]  R. J. Lee.  beta-Adrenergic blockade in acute myocardial infarction. , 1978, Life sciences.

[39]  R. Branch,et al.  The Influence of Cirrhosis on Steady-State Blood Concentrations of Unbound Propranolol after Oral Administration , 1978, Clinical pharmacokinetics.

[40]  M. Weil,et al.  Effect of afterload reduction on plasma volume during acute heart failure. , 1978, The American journal of cardiology.

[41]  R. Vestal,et al.  Direct measurement of propranolol bioavailability during accumulation to steady-state. , 1978, British journal of clinical pharmacology.

[42]  D. Richards,et al.  Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol , 1978, Clinical pharmacology and therapeutics.

[43]  P. Edlund,et al.  Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients. , 1978, British journal of clinical pharmacology.

[44]  A. Wood,et al.  Editorial: Propranolol Withdrawal Syndrome Why? , 1978, Circulation.

[45]  H. Refsum,et al.  Acebutolol-induced changes in refractoriness and monophastic action potential of the right ventricle of the dog heart in situ. , 1978, Cardiovascular Research.

[46]  S. Snyder,et al.  Prazosin: differential affinities for two populations of α-noradrenergic receptor binding sites , 1978 .

[47]  H. Gohlke,et al.  Hemodynamic effects of intravenous phentolamine in low output cardiac failu;e. Dose-response relationships. , 1978, Circulation.

[48]  M. A. Katz,et al.  Oral clonidine loading for rapid control of hypertension , 1978, Clinical pharmacology and therapeutics.

[49]  M. E. Goldberg,et al.  Direct Myocardial Depressant Effects of Several β-Adrenergic Blocking Agents in the Unanesthetized Atherosclerotic Rabbit , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[50]  T. Whitsett,et al.  Abrupt cessation of clonidine administration: a prospective study. , 1978, The American journal of cardiology.

[51]  D. Richards,et al.  Circulatory and alpha-adrenoceptor blocking effects of phentolamine. , 1978, British journal of clinical pharmacology.

[52]  D. Lowenthal,et al.  Timolol kinetics in chronic renal insufficiency , 1978, Clinical pharmacology and therapeutics.

[53]  W. Griffith,et al.  The protective effect of phentolamine against cardiac arrhythmias in the rat. , 1978, European journal of pharmacology.

[54]  Kenneth L. Melmon,et al.  Clinical Pharmacology: Basic Principles in Therapeutics , 1978 .

[55]  A. Niarchos.  Evaluation of Intravenous Clonidine in Hypertensive Emergencies , 1978, Journal of clinical pharmacology.

[56]  D. Richards,et al.  Concurrent antagonism of isoproterenol and norepinephrine after labetalol , 1978, Clinical pharmacology and therapeutics.

[57]  J. Cruickshank,et al.  Beta-blockers and asthma. , 1978, British heart journal.

[58]  R. Branch,et al.  Biological determinants of propranolol disposition in man , 1978, Clinical pharmacology and therapeutics.

[59]  J. V. Nixon,et al.  Efficacy of Propranolol in the Control of Exercise‐Induced or Augmented Ventricular Ectopic Activity , 1978, Circulation.

[60]  R. Miller,et al.  Comparison of Effects of Nitroprusside and Prazosin on Left Ventricular Function and the Peripheral Circulation in Chronic Refractory Congestive Heart Failure , 1978, Circulation.

[61]  A. Damato,et al.  Effect of procainamide on reentry within the His-Purkinje system in man. , 1977, The American journal of cardiology.

[62]  D. Barnett,et al.  Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics. , 1977, British medical journal.

[63]  E. Vesell.  Genetic and environmental factors affecting drug disposition in man , 1977, Clinical pharmacology and therapeutics.

[64]  A. Zanchetti,et al.  Relation between the hypotensive and renin-suppressing activities of alpha methyldopa in hypertensive patients. , 1977, The American journal of cardiology.

[65]  H. Boudoulas,et al.  Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. , 1977, Annals of internal medicine.

[66]  W. Pettinger,et al.  A functional basis for classification of α-adrenergic receptors , 1977 .

[67]  R. Miller,et al.  Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. , 1977, The New England journal of medicine.

[68]  A. Mclean,et al.  PLASMA LEVELS FOLLOWING SINGLE INTRAVENOUS, ORAL AND MULTIPLE ORAL DOSAGE IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS , 1977 .

[69]  J. Mahony,et al.  LONG‐TERM USE OF PRAZOSIN IN COMBINATION OR ALONE FOR TREATING HYPERTENSION , 1977, The Medical journal of Australia.

[70]  L. Shenkman,et al.  Hyperthyroidism after propranolol withdrawal. , 1977, JAMA.

[71]  T. Pickering,et al.  Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade. , 1977, British medical journal.

[72]  A. Melander,et al.  Enhancement of the bioavailability of propranolol and metoprolol by food , 1977, Clinical pharmacology and therapeutics.

[73]  C. Dollery,et al.  CLONIDINE WITHDRAWAL IN HYPERTENSION Changes in Blood-pressure and Plasma and Urinary Noradrenaline , 1977, The Lancet.

[74]  E. Raftery,et al.  Blood pressure and heart rate and withdrawal of antihypertensive drugs. , 1977, British medical journal.

[75]  J. M. Shaw,et al.  Metabolic Studies in Patients with Nadolol: Oral and Intravenous Administration , 1977, Journal of clinical pharmacology.

[76]  Adesh K. Jain,et al.  Efficacy and acceptability of different dosage schedules of clonidine , 1977, Clinical pharmacology and therapy.

[77]  Z. Petryka,et al.  Unusual Watson-Schwartz test from methyldopa. , 1977, The New England journal of medicine.

[78]  C. Dollery,et al.  Apparent resistance to hypotensive effect of clonidine. , 1977, British medical journal.

[79]  J. Wright,et al.  Antihypertensive efficacy of a single bedtime dose of methyldopa , 1976, Clinical pharmacology and therapy.

[80]  J. Laragh,et al.  Renin and aldosterone suppression in the antihypertensive action of clonidine. , 1976, The American journal of cardiology.

[81]  M. Hetzel,et al.  Comparison of intravenous and aerosol salbutamol. , 1976, British medical journal.

[82]  R. Shanks,et al.  Uses of Beta-Adrenoceptor Blocking Drugs , 1976, Journal of the Royal College of Physicians of London.

[83]  L. Gould,et al.  Hemodynamic effects of steroids in cardiac disease. , 1976, American heart journal.

[84]  D. Shand,et al.  Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. , 1976, The New England journal of medicine.

[85]  J. Counsell,et al.  Acute coronary syndromes following abrupt cessation of oral propranolol therapy. , 1976, Canadian Medical Association journal.

[86]  S. Alexander,et al.  Letter: Propranolol treatment of VPB's. , 1976, New England Journal of Medicine.

[87]  W. T. Simpson,et al.  Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug. , 1976, British journal of clinical pharmacology.

[88]  M. Weil,et al.  Afterload reduction with phentolamine in patients with acute pulmonary edema. , 1976, The American journal of medicine.

[89]  D. Knapp,et al.  Qualitative metabolic fate of phenoxybenzamine in rat, dog, and man. Use of 15N-labeling. , 1976, Drug metabolism and disposition: the biological fate of chemicals.

[90]  F. Abboud,et al.  Reflex control of the peripheral circulation. , 1976, Progress in cardiovascular diseases.

[91]  C. Kaye,et al.  Absorption of propranolol and practolol in Coeliac disease. , 1976, Gut.

[92]  J. Reid,et al.  Clinical pharmacology and pharmacokinetics of clonidine , 1976, Clinical pharmacology and therapeutics.

[93]  D. Harrison,et al.  Investigation of the safe withdrawal period for propranolol in patients scheduled for open heart surgery. , 1975, British heart journal.

[94]  J. R. Curtis,et al.  Use of prazosin in management of hypertension in patients with chronic renal failure and in renal transplant recipients. , 1975, British medical journal.

[95]  Pitts Ne.  The clinical evaluation of prazosin, a new antihypertensive agent. , 1975 .

[96]  J. K. Nelson,et al.  Comparative trial of propranolol and practolol in hyperthyroidism. , 1975, British journal of clinical pharmacology.

[97]  D. Tocco,et al.  Physiological disposition and metabolism of timolol in man and laboratory animals. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[98]  R. Miller,et al.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. , 1975, The New England journal of medicine.

[99]  C. Kaye,et al.  The effect of age on plasma levels of propranolol and practolol in man. , 1975, British journal of clinical pharmacology.

[100]  A. Zanchetti,et al.  Studies of the Absorption and Removal of Propranolol in Hypertensive Patients during Therapy , 1975, Circulation.

[101]  M. F. Green.  Points from Letters: Injudicious First-aid , 1975 .

[102]  C. Rosendorff,et al.  Clinical evaluation of prazosin as the sole agent for the treatment of hypertension: a double-blind cross-over study with methyldopa. , 1975, Current therapeutic research, clinical and experimental.

[103]  J. Boitnott,et al.  Severe hepatitis from methyldopa. , 1975, Gastroenterology.

[104]  Mcmahon Fg.  Efficacy of an antihypertensive agent. Comparison of methyldopa and hydrochlorothiazide in combination and singly. , 1975 .

[105]  M. Josephson,et al.  The electrophysiology of propranolol in man. , 1974, American heart journal.

[106]  D. Lowenthal,et al.  Pharmacokinetics of oral propranolol in chronic renal disease , 1974, Clinical pharmacology and therapeutics.

[107]  L. Wilhelmsen,et al.  Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. , 1974, Lancet.

[108]  D. Harrison,et al.  Coronary artery syndromes after sudden propranolol withdrawal. , 1974, Annals of internal medicine.

[109]  D. Shand.  Individualization of propranolol therapy. , 1974, The Medical clinics of North America.

[110]  R. Tarazi.  Sympathomimetic agents in the treatment of shock. , 1974, Annals of internal medicine.

[111]  W. Mroczek,et al.  Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo. , 1974, Current therapeutic research, clinical and experimental.

[112]  M. Weber,et al.  Prazosin: Preliminary Report and Comparative Studies with Other Antihypertensive Agents , 1974, British medical journal.

[113]  R. Shanks,et al.  The assessment of β-adrenoceptor blocking drugs in hyperthyroidism. , 1974, British journal of clinical pharmacology.

[114]  C. Dollery,et al.  Cardiovascular effects of intracerebroventricular d-, l- and dl-propranolol in the conscious rabbit. , 1974, The Journal of pharmacology and experimental therapeutics.

[115]  J. Young,et al.  Time required for complete recovery from chronic propranolol therapy. , 1973, The New England journal of medicine.

[116]  J. Laragh,et al.  Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. , 1973, The American journal of cardiology.

[117]  J. Somberg,et al.  Withdrawal of propranolol and myocardial infarction. , 1973, Lancet.

[118]  B. Pitt,et al.  Use of Phentolamine in Acute Myocardial Infarction Associated with Hypertension and Left Ventricular Failure , 1973, Circulation.

[119]  A. Roach,et al.  -Adrenergic receptors in the central nervous system of the cat concerned with control of arterial blood pressure and heart rate. , 1973, Nature: New biology.

[120]  C. Dollery,et al.  Interaction between Clonidine and Desipramine in Man , 1973, British medical journal.

[121]  R. Slome.  Withdrawal of propranolol and myocardial infarction. , 1973, Lancet.

[122]  C. Dollery,et al.  Metabolism of isoprenaline in dog and man , 1972, British journal of pharmacology.

[123]  F. Estafanous,et al.  Propranolol and cardiac surgery. , 1972, The Journal of thoracic and cardiovascular surgery.

[124]  J. Pryor.  Diagnosis of Ruptured Aneurysm of Abdominal Aorta , 1972, British medical journal.

[125]  F. Zak,et al.  Cardiomyopathy associated with a pheochromocytoma. Report of a case with ultrastructural examination of the myocardial lesions. , 1972, Archives of pathology.

[126]  F. Thompson,et al.  Pharmacodynamics of Propranolol in Renal Failure , 1972, British medical journal.

[127]  J. Fitzgerald,et al.  Pharmacology of 4‐hydroxypropranolol, a metabolite of propranolol , 1971, British journal of pharmacology.

[128]  Coltart Dj,et al.  The effect of racemic propranolol, dextro-propranolol and racemic practolol on the human and canine cardiac transmembrane action potential (beta blockade and the cardiac action potential). , 1971 .

[129]  A. Schwartz,et al.  Antihypertensive Effect of Clonidine , 1971, Circulation research.

[130]  D. Shand,et al.  Plasma Propranolol Levels Associated with Suppression of Ventricular Ectopic Beats , 1971, British medical journal.

[131]  M. Nickerson.  Vascular adjustments during the development of shock. , 1970, Canadian Medical Association journal.

[132]  J. Hamer,et al.  The effect of propranolol on the human and canine transmembrane action potential. , 1970, British journal of pharmacology.

[133]  B. Singh,et al.  The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle , 1970, British journal of pharmacology.

[134]  J. Vane,et al.  The inactivation of noradrenaline and isoprenaline in dogs , 1970, British journal of pharmacology.

[135]  P. Olley,et al.  The surdo-cardiac syndrome and therapeutic observations , 1970, British heart journal.

[136]  H. Hedeland,et al.  Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients. , 1970, European journal of pharmacology.

[137]  A. Damato,et al.  Electrophysiologic effects of bretylium tosylate on single fibers of the canine specialized conducting system and ventricle. , 1970, The Journal of pharmacology and experimental therapeutics.

[138]  J. Oates,et al.  Plasma propranolol levels in adults With observations in four children , 1970, Clinical pharmacology and therapeutics.

[139]  A. Damato,et al.  The Effects of Propranolol on Cardiac Conduction , 1969, Circulation.

[140]  A. Wilson,et al.  Mechanism of action of βadrenergic receptor blocking agents in angina pectoris: Comparison of action of propranolol with dexpropranolol and practolol , 1969, British medical journal.

[141]  A. Muir,et al.  Circulatory effects at rest and exercise of clonidine, an imidazoline derivative with hypotensive properties. , 1969, Lancet.

[142]  E. Sowton,et al.  The use of beta-adrenergic receptor blocking drugs in dysrhythmias. , 1969, Progress in cardiovascular diseases.

[143]  J. Riordan,et al.  Effects of Phenoxybenzamine in Shock due to Myocardial Infarction , 1969, British medical journal.

[144]  E. Zaimis.  Vasopressor Drugs and Catecholamines , 1968, Anesthesiology.

[145]  W. Conway,et al.  Absorption and elimination profile of isoproterenol. 3. The metabolic fate of dl-isoproterenol-7-3H in the dog. , 1968, Journal of pharmaceutical sciences.

[146]  L. D. Davis,et al.  Effects of Propranolol on the Transmembrane Potentials of Ventricular Muscle and Purkinje Fibers of the Dog , 1968, Circulation research.

[147]  R. B. Bruce,et al.  The determination and excretion of phenylephrine in urine , 1968 .

[148]  A. M. Lands,et al.  Differentiation of receptors responsive to isoproterenol. , 1967, Life sciences.

[149]  J. Cohn,et al.  Blood pressure measurement in shock. Mechanism of inaccuracy in ausculatory and palpatory methods. , 1967, JAMA.

[150]  A. Lobuglio,et al.  The nature of the alpha-methyldopa red-cell antibody. , 1967, The New England journal of medicine.

[151]  E. Williams.  Mode of action of beta receptor antagonists on cardiac muscle. , 1966, The American journal of cardiology.

[152]  W. Conway,et al.  Absorption and Elimination Profile of Isoproterenol III , 1965 .

[153]  E. Williams,et al.  THE EFFECTS ON CARDIAC MUSCLE OF β‐RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS , 1965 .

[154]  G. Sutherland,et al.  THE CIRCULATORY EFFECTS OF PHENTOLAMINE IN MAN WITH PARTICULAR RESPECT TO CHANGES IN FOREARM BLOOD FLOW. , 1965, Clinical science.

[155]  J. Cohn.  Comparative Cardiovascular Effects of Tyramine, Ephedrine, and Norepinephrine in Man , 1965, Circulation research.

[156]  P. Gillam,et al.  Use of Propranolol (Inderal) in Treatment of Hypertension , 1964, British medical journal.

[157]  J. Walsh,et al.  SUSTAINED-RELEASE PRINCIPLE IN HUMAN SUBJECTS UTILIZING RADIOACTIVE TECHNIQUES. , 1964, Journal of Pharmacy and Science.

[158]  C. Dollery,et al.  HÆMODYNAMIC STUDIES WITH METHYLDOPA: EFFECT ON CARDIAC OUTPUT AND RESPONSE TO PRESSOR AMINES , 1963, British heart journal.

[159]  M. Nickerson,et al.  Blockade of sympathetic vasoconstriction in the treatment of shock. , 1962, The Journal of trauma.

[160]  A. Sjoerdsma,et al.  Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanine , 1960, Science.

[161]  D. Aviado.  CARDIOVASCULAR EFFECTS OF SOME COMMONLY USED PRESSOR AMINES , 1959, Anesthesiology.

[162]  M. Nickerson.  The pharmacology of adrenergic blockade. , 1949, The Journal of pharmacology and experimental therapeutics.

[163]  R. Ahlquist,et al.  A study of the adrenotropic receptors. , 1948, The American journal of physiology.

[164]  Petrie Wm,et al.  Propranolol and depression. , 1982 .

[165]  T. Philipp,et al.  Hypertension, mechanisms and management , 1980 .

[166]  L. Szekeres.  Adrenergic Activators and Inhibitors , 1980, Handbook of Experimental Pharmacology.

[167]  M. Anlauf.  Hemodynamic reactions under various stimuli before and during chronic beta-blockade. , 1980, Archives internationales de pharmacodynamie et de therapie.

[168]  M. E. Charness,et al.  EXACERBATION OF ANGINA PECTORIS BY PRAZOSIN? , 1979, Southern medical journal.

[169]  E. Müller-Schweinitzer,et al.  Basic Pharmacological Properties , 1978 .

[170]  J. Oates,et al.  The Clinical Pharmacology of Antihypertensive Drugs , 1977 .

[171]  E. Santiago-delpin,et al.  Histamine and sympathetic blockade in septic shock. , 1977, The American surgeon.

[172]  R. Sega,et al.  Pharmacokinetics and Effects of Propranolol in Terminal Uraemic Patients and in Patients Undergoing Regular Dialysis Treatment , 1976, Clinical pharmacokinetics.

[173]  M. J. Davey,et al.  A review of the biological effects of prazosin, including recent pharmacological findings , 1976 .

[174]  W. W. Guthrie,et al.  Letter: Vibrio parahaemolyticus. , 1976, JAMA.

[175]  Shanks Rg,et al.  The properties of beta-adrenoceptor antagonists. , 1976 .

[176]  J. Crooks,et al.  Pharmacokinetics in the Elderly , 1976, Clinical pharmacokinetics.

[177]  E. Amsterdam,et al.  The propranolol withdrawal rebound phenomenon: Acute and catastrophic exacerbation of symptoms and death following the abrupt cessation of large doses of propranolol in coronary artery disease , 1975 .

[178]  Williams,et al.  Classification of antiarrhythmic drugs , 1975 .

[179]  S. Allison,et al.  Letter: Elemental diets. , 1975, Lancet.

[180]  E. Kohner,et al.  Letter: Bromocritine and serum-growth-hormone levels in diabetes mellitus. , 1975, Lancet.

[181]  M. Hayden,et al.  A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs. , 1975, European journal of pharmacology.

[182]  D. Sharman,et al.  The Distribution of Catecholamines in Vertebrates , 1972 .

[183]  Shand Dg,et al.  The disposition of propranolol. I. Elimination during oral absorption in man. , 1972 .

[184]  M. Sandler.  Catecholamine Synthesis and Metabolism in Man: Clinical Implications (With Special Reference to Parkinsonism) , 1972 .

[185]  D. Shand,et al.  The Disposition of Propranolol , 1972 .

[186]  I. Kopin.  Metabolic Degradation of Catecholamines. The Relative Importance of Different Pathways under Physiological Conditions and after Administration of Drugs , 1972 .

[187]  J. W. Miller,et al.  Drugs affecting smooth muscle. , 1969, Annual review of pharmacology.

[188]  A. Scriabine,et al.  Antihypertensive 2-amino-4(3H)-quinazolinones. , 1968, Journal of medicinal chemistry.

[189]  F. Abboud,et al.  Circulatory effects of sympathomimetic amines. , 1962, American heart journal.

[190]  J. V. Maloney,et al.  Intravenous 1-norepinephrine as a casue of reduced plasma volume. , 1961, Surgery.

[191]  A. Keys,et al.  THE CARDIO-CIRCULATORY EFFECTS IN MAN OF NEO-SYNEPHRIN (1-α-hydroxy-β-methylamino-3-hydroxy-ethylbenzene hydrochloride) , 1942 .

[192]  J. N. Langley.  THE AUTONOMIC NERVOUS SYSTEM , 1903 .